Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Prospective Multicentric Trial Evaluating Etravirine for HIV Infected Patients in Need of Lipid Lowering Drugs: the ETRALL Trial

NCT01543035 is registered in ClinicalTrials.gov with Calmy Alexandra as lead sponsor.

NCT NCT01543035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01543035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Prospective Multicentric Trial Evaluating Etravirine for HIV Infected Patients in Need of Lipid Lowering Drugs: the ETRALL Trial
Lead sponsor
Calmy Alexandra
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
August 31, 2013
Enrollment
34 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection